Additionally, studies have found that RAB3B can act as a hub gene in the diagnosis and prognosis prediction of lung adenocarcinoma, glioma, prostate cancer, gastric cancer, and colorectal cancer30–35. This evidence concerns the gene RAB3B and prostate cancer.